Dienogest interrupts the chemokine signalling axis in endometriotic lesions with resistant signatures providing novel opportunities for personalised treatment.
Fields of Study & Subjects
Endometriosis Research and Treatment
Endometrial and Cervical Cancer Treatments
Ectopic Pregnancy Diagnosis and Management
Publication details
- Journal / source
- Research Square
- Publication date
- 13 January 2026
- Document type
- Preprint